U.S. Markets closed

Rexahn Pharmaceuticals, Inc. (RNN)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
2.28-0.08 (-3.39%)
At close: 4:00PM EDT

2.28 0.00 (0.00%)
After hours: 5:28PM EDT

People also watch
MSTXGALEAEZSIMUCINO
Full screen
Previous Close2.36
Open2.37
Bid0.00 x
Ask0.00 x
Day's Range2.25 - 2.37
52 Week Range0.13 - 4.74
Volume119,538
Avg. Volume574,563
Market Cap64.87M
Beta0.29
PE Ratio (TTM)-1.93
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Rodman & Renshaw Encouraged on Rexahn Pharmaceuticals, Inc. (RNN) Following ASCO Update
    SmarterAnalyst2 months ago

    Rodman & Renshaw Encouraged on Rexahn Pharmaceuticals, Inc. (RNN) Following ASCO Update

    Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) offered a key glimpse into its advanced muscle invasive bladder cancer (MIBC) Phase 2a trial  at the American Society of Clinical Oncology conference over the weekend. In reaction, Rodman & Renshaw Joseph Pantginis sees beneficial opportunity for bladder cancer patients and is bullish on the firm's pipeline drug, reiterating a Buy rating on shares of RNN with a $19.50 price target, which represents a 391% increase from current levels.

  • Associated Press3 months ago

    Rexahn reports 1Q loss

    The Rockville, Maryland-based company said it had a loss of 9 cents per share. Losses, adjusted for non-recurring costs, were 2 cents per share. The company's shares closed at 40 cents. A year ago, they ...

  • Investopedia4 months ago

    Penny Stocks to Watch for April 2017 (ATRS, WRN)

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.